SPPI News and Press, Spectrum Pharmaceuticals Inc. From 02/28/22

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced an oral presentation on poziotinib at the European Society for Medical Oncology (ESMO) Targeted Anticancer Therapies (TAT) Congress 2022 being held vi...

A spate of bad luck has destroyed SPPI stock. CEO and CFO have both resigned. Even if, somehow, ROLONTIS gets approved, they don't have the cash to commercialize. For further details see: Spectrum Pharmaceuticals: Some Last Words

The shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) are trading marginally lower in the pre-market on Wednesday after the commercial-stage biotech company announced the resignation of its Chief Financial Officer Kurt Gustafson. According to a regulatory filing, Mr. Gustafson has notified the...

This week has gotten off to a rocky start, thanks to the news over the weekend. The latest on the Ukraine-Russia crisis has some fearing for an international conflict. Sources have cited that Russian troops poured into Ukraine’s “breakaway” region, leading to global pow...

The U.S. Food and Drug Administration (FDA) accepted for review Spectrum Pharmaceuticals' (NASDAQ:SPPI) new drug application (NDA) for poziotinib to treat patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 20 insertion mutat...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that its New Drug Application (NDA) for poziotinib has been accepted for review by the U.S. Food and Drug Administration (FDA). The NDA acceptance...

Penny stocks are one of the most volatile asset classes in the stock market today and for a good reason. Day-in and day-out, we write about these small companies as traders hunt for the next big breakout stock. Swift moves higher thanks to a mix of catalysts and speculation have trigger...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! The week is almost done but we’re not slacking as we check out the biggest pre-market stock movers for Friday! Source: Shutterstock Earnings reports, an investor conference, one compan...

Constellation Energy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Constellation Energy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , Jan. 26, 2022 /PRNewswire/...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will participate in the B. Riley Securities 2022 Virtual Oncology Conference. A fireside chat is scheduled for Thursday, January 27, 2...